Levosimendan: perpetuum mobile?

Eur Heart J. 2007 Feb;28(4):515. doi: 10.1093/eurheartj/ehl487. Epub 2007 Feb 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cardiac Output / drug effects
  • Cardiotonic Agents / therapeutic use*
  • Heart Failure / drug therapy*
  • Humans
  • Hydrazones / therapeutic use*
  • Myocardial Contraction / drug effects
  • Pyridazines / therapeutic use*
  • Simendan

Substances

  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Simendan